Variation in retinal changes and muscle pathology in mitochondriopathies

  • Jürgen Bosche
  • Wolfgang Hammerstein
  • Eva Neuen-Jacob
  • Ralf Schober
Laboratory Investigations

Abstract

A variety of retinal changes that have so far not been classified under mitochondriopathies can now be included in this group, since muscle biopsy has identified ragged-red fibers with pathological mitochondriae. The ophthalmological findings in our relatively large group of 12 patients with mitochondrial myopathies are compared with the spectrum of myopathic findings. No obvious correlation exists between the severity of the pathological retinal changes and the characteristic of the myopathic alterations. In addition to fine pigmentation and depigmentation, severe dystrophic changes of the retina, pigment epithelium, and the choroid were observed. In two patients with severe chorioretinal dystrophy the correlation with generalized mitochondriopathy was not suspected prior to muscle biopsy.

Keywords

Public Health Retina Myopathy Muscle Biopsy Pigment Epithelium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bachynski BN, Flynn JT, Rodrigues MM, Rosenthal S, Cullen R, Curless RG (1986) Hyperglycemic acidotic coma and death in Kearns-Sayre syndrome. Ophthalmology 93:391–396PubMedGoogle Scholar
  2. 2.
    Bastiaensen LAK (1978) Pigment changes of the retina in chronic progressive external ophthalmoplegia (CPEO). Acta Ophthalmol 5 [Suppl] 138Google Scholar
  3. 3.
    Bastiaensen LAK, Frenken CWGM, Ter Laak HJ, Jaspar HHJ, Stadhouders AM, Ruitenbeek W, Veerkamp JH (1982) Kearns syndrome: a heterogeneous group of disorders with CPEO, or a nosological entity? Doc Ophthalmol 52:207–225PubMedGoogle Scholar
  4. 4.
    Bastiaensen LAK, Notermans SLH, Ramaekers CH, van Dijke BJ, Joosten EMG, Jaspar HHJ, Stadhouders AM, Beljaars CTE (1982) Kearns syndrome or Kearns disease. Further evidence of a genuine entity in a case with uncommon features. Ophthalmologica 184:40–50PubMedGoogle Scholar
  5. 5.
    Berdjis H, Heider W, Demisch K (1984) ERG und VECP bei chronisch-progressiver externer Ophthalmoplegie. Klin Monatsbl Augenheilkd 185:113–118PubMedGoogle Scholar
  6. 6.
    Berenberg RA, Pellock JM, DiMauro S, Schotland DL, Bonilla E, Eastwood A, Hays A, Vicale CT, Behrens M, Chutorian A, Rowland LP (1977) Lumping or splitting? “Ophthalmoplegia-plus” or Kearns-Sayre syndrome? Ann Neurol 1:37–54PubMedGoogle Scholar
  7. 7.
    Boltshauser E, Jerusalem F, Niemeyer G, Huber CH (1977) Kearns-Syndrom. Schweiz Med Wochenschr 107:1880–1888PubMedGoogle Scholar
  8. 8.
    Boustany RN, Aprille JR, Halperin J, Levy H, DeLong GR (1983) Mitochondrial cytochrome deficiency presenting as a myopathy with hypotonia, external ophthalmolplegia, and lactic acidosis in an infant and as fatal hepatopathy in a second cousin. Ann Neurol 14:462–470PubMedGoogle Scholar
  9. 9.
    Byrne E, Blumbergs PC, Hallpike JF, Mukherjee TM (1983) Clinical features of mitochondrial myopathy. Aust NZ J Med 13:353–358Google Scholar
  10. 10.
    Byrne E, Dennett X, Trounce I, Henderson R (1985) Partial cytochrome oxidase (aa3) deficiency in chronic progressive external ophthalmoplegia. Histochemical and biochemical studies. J Neurol Sci 71:257–271PubMedGoogle Scholar
  11. 11.
    DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo D (1985) Mitochondrial myopathies. Ann Neurol 17:521–538PubMedGoogle Scholar
  12. 12.
    Drachman DA (1968) Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18:654–674PubMedGoogle Scholar
  13. 13.
    Dubowitz V (1985) Muscle biopsy, a practical approach. VI. Baillière Tindall, LondonGoogle Scholar
  14. 14.
    Eagle RC, Hedges TR, Yanoff M (1982) The atypical pigmentary retinopathy of Kearns-Sayre syndrome. A light- and electron microscopic study. Ophthalmology 89:1433–1440PubMedGoogle Scholar
  15. 15.
    Gonska BD, Bethge KP, Holzgraefe M, Rahlf G, Kreuzer H (1985) Elektrophysiologische Befunde bei Patienten mit Kearns-Sayre-Syndrom-Bericht über zwei Fälle. Z Kardiol 74:281–286PubMedGoogle Scholar
  16. 16.
    Hammersen F, Gidlof A, Larsson J, Lewis DH (1980) The occurrence of paracrystalline mitochondrial inclusions in normal skeletal muscle. Acta Neuropathol 49:41–47Google Scholar
  17. 17.
    Hammerstein W, Mortier W, Noack EA, Frenzel H, Liebert UG, Toyka K, Horstkotte D, Bischof G, Weber U (1983) Klinische, morphologische und biochemische Befunde beim Kearns-Sayre-Syndrom. Fortschr Ophthalmol 80: 193–200PubMedGoogle Scholar
  18. 18.
    Hammerstein W, Seitz RJ, Toyka K, Schwarzkopff B (1986) Netzhautdystrophie bei Mitochondriopathie. Fortschr Ophthalmol 83:320–324PubMedGoogle Scholar
  19. 19.
    Hennekes R (1982) Die Intensitätsabhängigkeit der ERG-Komponenten und ihre klinische Bedeutung. Habilitationsschrift, University of DüsseldorfGoogle Scholar
  20. 20.
    Jerusalem F (1979) Muskelerkrankungen. Thieme, Stuttgart, pp 7–12Google Scholar
  21. 21.
    Johnson MA, Turnbull DM, Dick DJ, Sherratt HS (1983) A partial deficiency of cytochrome-c-oxidase in chronic progressive external ophthalmoplegia. J Neurol Sci 60:31–53PubMedGoogle Scholar
  22. 22.
    Karpati G, Carpenter S, Larbrisseau A, La Fontaine R (1973) The Kearns-Shy syndrome. A multisystem disease with mitochondrial abnormality demonstrated in skeletal muscle and skin. J Neurol Sci 19:133–151PubMedGoogle Scholar
  23. 23.
    Kearns TP, Sayre GP (1958) Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch Ophthalmol 60:280–289Google Scholar
  24. 24.
    Leveille ASF, Newell FW (1980) Autosomal dominant Kearns-Sayre syndrome. Ophthalmology 87:99–108PubMedGoogle Scholar
  25. 25.
    McKechnie NM, King M, Lee WR (1985) Retinal pathology in the Kearns-Sayre syndrome. Br J Ophthalmol 69:63–75PubMedGoogle Scholar
  26. 26.
    Mechler F, Mastaglia FL, Serena M, Jenkison M, Johnson MA, Fawcett PR, Hudgson P, Walton JN (1986) Mitochondrial myopathies. A clinical-pathological study of cases with and without extra-ocular muscle involvement. Aust NZ J Med 16: 185–192Google Scholar
  27. 27.
    Mitsumoto H, Aprille JR, Wray SH, Nemni R, Bradley WG (1983) Chronic progressive external ophthalmoplegia (CPEO): clinical, morphological, and biochemical studies. Neurology 33:452–461PubMedGoogle Scholar
  28. 28.
    Mukherjee TM, Dixon BR, Blumbergs PC, Swift JG, Hallpike JF (1986) The fine structure of the intramitochondrial crystalloids in mitochondrial myopathy. J Submicrosc Cytol 18:595–604PubMedGoogle Scholar
  29. 29.
    Newell FW (1979) Mitochondrial disease and retinal pigmentary degeneration. Exerpta Medica International Congress Series, vol 450. Exerpta Medica, Amsterdam, pp 611–615Google Scholar
  30. 30.
    Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahshi M, Hashimoto S, Kono N, Tarui S (1986) Treatment of Kearns-Sayre syndrome with coenzyme Q 10. Neurology 36:45–53PubMedGoogle Scholar
  31. 31.
    Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T, Nakamura Y, Hashimoto S, Kono N, Tarui S (1985) Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q 10 in Kearns-Sayre syndrome. Neurology 35:372–377PubMedGoogle Scholar
  32. 32.
    Olson W, Engel WK, Walsh GO (1972) Oculocraniosomatic neuromuscular disease with “ragged-red” fibers. Arch Neurol 26:193–211PubMedGoogle Scholar
  33. 33.
    Pongratz D, Perwein J, Huebner G, Koppenwallner C, Toyka K, Birnberger KL (1979) Wertigkeit der Skelettmuskelbiopsie bei progressiver externer Ophthalmoplegie. Klin Wochenschr 57:779–788PubMedGoogle Scholar
  34. 34.
    Schneck L, Adachi M, Briet P, Wollnitz A, Volk BW (1973) Ophthalmoplegia plus with morphological and chemical studies of cerebellar and muscle tissue. J Neurol Sci 19:37–44PubMedGoogle Scholar
  35. 35.
    Steindler P, Tormene AP, Micaglio GF, Galan A (1985) Correlation of ERG and pigment epithelium changes in external progressive ophthalmoplegia (PEO). Doc Ophthalmol 60:421–426PubMedGoogle Scholar
  36. 36.
    Weidauer H, Lenarz T (1984) Das Kearns-Sayre Syndrom aus hals-nasenohrenärztlicher Sicht. Laryngol Rhinol Otolaryngol (Stuttg) 63:141–146Google Scholar
  37. 37.
    Yorifuji S, Ogasahara S, Takahashi M, Tarui S (1985) Decreased activities in mitochondrial inner membrane electron transport system in muscle from patients with Kearns-Sayre syndrome. J Neurol Sci 71:65–75PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • Jürgen Bosche
    • 1
  • Wolfgang Hammerstein
    • 1
  • Eva Neuen-Jacob
    • 2
  • Ralf Schober
    • 2
  1. 1.AugenklinikDüsseldorfFederal Republic of Germany
  2. 2.Institut für Neuropathologie der UniversitätDüsseldorfFederal Republic of Germany

Personalised recommendations